Desmopressin for treating nocturia in men

Prediction of nocturnal polyuria in patients with nocturia based on voiding frequency

PURPOSE

To examine daytime voiding patterns in patients with nocturnal polyuria (NP) and identify a novel predictive indicator based on voiding frequency ratios.

METHODS

A retrospective analysis of 875 patients with nocturia from 17 Japanese institutions (January 2018-December 2022) was conducted. Patients were divided into two groups based on the nocturnal polyuria index (NPi) > 33% (NP) or ≤ 33% (non-NP). Daytime and nighttime voiding frequencies and volumes were collected from bladder diaries. The correlation between the NPi and voiding parameters was assessed using Spearman's rank correlation. Receiver operating characteristic (ROC) curve analysis was performed to evaluate the predictive ability of the nighttime-to-24-h voiding frequency ratio for NP.

RESULTS

Patients with NP urinated significantly less frequently and produced more urine during the day than those without NP (p < 0.001). The ratio of nocturnal to 24-h voiding frequency showed a significant positive correlation with NPi (r = 0.38, p < 0.001) and was the strongest predictor of NP. ROC curve analysis showed that this ratio could predict NP, with an area under the curve (AUC) of 0.79. A cutoff value of 0.23 yielded 75% sensitivity and 68% specificity for predicting NP.

CONCLUSIONS

This study demonstrates that patients with NP exhibit significantly reduced daytime voiding frequency and urine volume compared with those without NP. The nighttime-to-24-h voiding is useful for roughly predicting NP at the time of the initial consultation and has the potential to become more practical and accurate with further accumulation of data and research.

A Scientometric Visualization Analysis for Benign Prostatic Hyperplasia from 2016 to 2022

BACKGROUND

Benign prostatic hyperplasia (BPH) is a common urological disorder leading to dysuria in middle-aged and elderly men and significantly reduces the quality of life of patients. Technology for BPH has made a great progress, while there is still a lack of visual and summary literature to make the summary.

SUMMARY

The aims of the study were to identify the cooperation of authors, countries, institutions, and explore hot topics' prospects regarding research of BPH. Relevant original articles were obtained from the Web of Science (WoS) database between 2016 and 2022. CiteSpace software was used to perform the analysis and visualization of scientific productivity and emerging trends.

KEY MESSAGES

A total of 4,738 articles related to study of BPH were identified. We observed a gradual increase in the number of publications from 2016 to 2022. The USA dominated the field in all countries. Shanghai Jiao Tong University was the most productive institution in 6 years. Active cooperation between countries and between institutions was not observed. Journal of Urology was the most co-cited journal. Roehrborn CG (41 papers) was the most productive author and had the largest numbers of citations (820 co-citations) during the past 6 years. Close collaboration was not observed between the different authors. The main hot topics included matters related to BPH, urinary tract symptom, prostatic urethral lift, thermal therapy, and prostatic neoplasms. This scientometric study comprehensively reviewed publications related to BPH during the past 6 years using quantitative and qualitative methods, which can be used to forecast future research developments in BPH.

Primary enuresis in adults: pathogenesis, clinical course and modern approaches to treatment: A review

The review article presents current data on the epidemiology, classification, pathogenesis, risk factors, diagnosis, and features of the clinical course of primary enuresis in adults. The main methods of treatment of patients with primary enuresis are described in detail. It has been shown that in the treatment of this category of patients, the leading role is given to the use of a synthetic analogue of the antidiuretic hormone desmopressin. A detailed analysis of the pharmacological properties and clinical use of desmopressin in patients with primary enuresis is presented. The advantages of prescribing a sublingual form of desmopressin, which ensures its high efficiency and good tolerability of therapy.

Current Treatment for Benign Prostatic Hyperplasia

BACKGROUND

Benign prostatic hyperplasia (BPH) is characterized by the occurrence of.disorders of urine storage and bladder emptying. Most men over the age of 60 years are affected to some degree.

METHODS

A selective literature search with additional scrutiny of guidelines and meta-analyses.

RESULTS

The management of patients with BPH is complex. Emptying and retention disorders can be treated by various pharmacological and surgical means. Transurethral resection of the prostate (TURP) has long been considered the gold standard for operative treatment. Transurethral enucleation procedures show a better risk profile in some uses, however, and have, above all, largely displaced suprapubic prostatectomy. Numerous innovative treatment options have been developed in recent years, but their long-term effects remain to be determined. These treatment techniques can nevertheless be used in individual cases after thorough discussion with the patient.

CONCLUSION

The care of patients with BPH should be interdisciplinary. The efficacy and safety of many new developments in the area of pharmacological and minimally invasive treatment remain to be demonstrated in randomized trials.